Sanjit S Jolly
Overview
Explore the profile of Sanjit S Jolly including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
128
Citations
2834
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
dEntremont M, Seto A, Alrashidi S, Alansari O, Brochu B, Lemaire-Paquette S, et al.
Circ Cardiovasc Interv
. 2024 Jun;
17(8):e013817.
PMID: 38887948
Background: The learning curve for new operators performing ultrasound-guided transfemoral access (TFA) remains uncertain. Methods: We performed a pooled analysis of the FAUST (Femoral Arterial Access With Ultrasound Trial) and...
12.
dEntremont M, Tiong D, Sadeghirad B, McGrath B, Cioffi G, Garni T, et al.
Am J Cardiol
. 2024 May;
223:29-39.
PMID: 38768846
Evidence regarding the comparative efficacy of the different methods to determine the significance of coronary stenoses in the catheterization laboratory is lacking. We aimed to compare all available methods guiding...
13.
14.
Jolly S, Lee S, Mian R, Kedev S, Lavi S, Moreno R, et al.
Am J Cardiol
. 2024 Mar;
220:111-117.
PMID: 38447893
Our objective was to evaluate the clinical effectiveness of the SYNERGY stent (Boston Scientific Corporation, Marlborough, Massachusetts) in patients with ST-elevation myocardial infarction (STEMI). The only drug-eluting stent approved for...
15.
Siren M, Leivo J, Anttonen E, Jolly S, Dzavik V, Koivumaki J, et al.
Am Heart J
. 2023 Dec;
269:149-157.
PMID: 38109987
Background: ST-segment elevation myocardial infarction (STEMI) is associated with high morbidity and mortality worldwide. Simple electrocardiogram (ECG) tools, including ST-segment resolution (STR) have been developed to identify high-risk STEMI patients...
16.
dEntremont M, Alrashidi S, Seto A, Nguyen P, Marquis-Gravel G, Abu-Fadel M, et al.
EuroIntervention
. 2023 Oct;
20(1):66-74.
PMID: 37800723
Background: Randomised controlled trials of ultrasound (US)-guided transfemoral access (TFA) for coronary procedures have shown mixed results. Aims: We aimed to compare US-guided versus non-US-guided TFA from randomised data in...
17.
Conen D, Wang M, Popova E, Chan M, Landoni G, Cata J, et al.
Lancet
. 2023 Aug;
402(10413):1627-1635.
PMID: 37640035
Background: Higher levels of inflammatory biomarkers are associated with an increased risk of perioperative atrial fibrillation and myocardial injury after non-cardiac surgery (MINS). Colchicine is an anti-inflammatory drug that might...
18.
Leong D, Cirne F, Aghel N, Baro Vila R, Cavalli G, Ellis P, et al.
JACC CardioOncol
. 2023 Aug;
5(4):415-430.
PMID: 37614581
Invasive cardiac interventions are recommended to treat ST-segment elevation myocardial infarction, non-ST-segment elevation acute coronary syndromes, multivessel coronary disease, severe symptomatic aortic stenosis, and cardiomyopathy. These recommendations are based on...
19.
dEntremont M, Alazzoni A, Dzavik V, Sharma V, Overgaard C, Lemaire-Paquette S, et al.
EuroIntervention
. 2023 Jun;
19(5):e394-e401.
PMID: 37382909
Background: The optimal strategy to prevent no-reflow in ST-elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI) is unknown. Aims: We aimed to examine the effect of thrombectomy on...
20.
Leivo J, Anttonen E, Jolly S, Dzavik V, Koivumaki J, Tahvanainen M, et al.
J Electrocardiol
. 2023 Jun;
80:99-105.
PMID: 37295167
Background: The prognostic significance of Q waves and T-wave inversions (TWI) combined and separately in STEMI patients undergoing primary PCI has not been well established in previous studies. Methods: We...